Global Biosimilar of Remicade Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Biosimilar of Remicade Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 100mg/10ml
  • 1.2.3 500mg/50ml
• 1.3 Market by Application
  • 1.3.1 Global Biosimilar of Remicade Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Blood Disorders
  • 1.3.3 Oncology Diseases
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Biosimilar of Remicade Market Perspective (2016-2027)
• 2.2 Biosimilar of Remicade Growth Trends by Regions
  • 2.2.1 Biosimilar of Remicade Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Biosimilar of Remicade Historic Market Share by Regions (2016-2021)
  • 2.2.3 Biosimilar of Remicade Forecasted Market Size by Regions (2022-2027)
• 2.3 Biosimilar of Remicade Industry Dynamic
  • 2.3.1 Biosimilar of Remicade Market Trends
  • 2.3.2 Biosimilar of Remicade Market Drivers
  • 2.3.3 Biosimilar of Remicade Market Challenges
  • 2.3.4 Biosimilar of Remicade Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Biosimilar of Remicade Players by Revenue
  • 3.1.1 Global Top Biosimilar of Remicade Players by Revenue (2016-2021)
  • 3.1.2 Global Biosimilar of Remicade Revenue Market Share by Players (2016-2021)
• 3.2 Global Biosimilar of Remicade Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Biosimilar of Remicade Revenue
• 3.4 Global Biosimilar of Remicade Market Concentration Ratio
  • 3.4.1 Global Biosimilar of Remicade Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Biosimilar of Remicade Revenue in 2020
• 3.5 Biosimilar of Remicade Key Players Head office and Area Served
• 3.6 Key Players Biosimilar of Remicade Product Solution and Service
• 3.7 Date of Enter into Biosimilar of Remicade Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar of Remicade Breakdown Data by Type

• 4.1 Global Biosimilar of Remicade Historic Market Size by Type (2016-2021)
• 4.2 Global Biosimilar of Remicade Forecasted Market Size by Type (2022-2027)

5 Biosimilar of Remicade Breakdown Data by Application

• 5.1 Global Biosimilar of Remicade Historic Market Size by Application (2016-2021)
• 5.2 Global Biosimilar of Remicade Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Biosimilar of Remicade Market Size (2016-2027)
• 6.2 North America Biosimilar of Remicade Market Size by Type
  • 6.2.1 North America Biosimilar of Remicade Market Size by Type (2016-2021)
  • 6.2.2 North America Biosimilar of Remicade Market Size by Type (2022-2027)
  • 6.2.3 North America Biosimilar of Remicade Market Size by Type (2016-2027)
• 6.3 North America Biosimilar of Remicade Market Size by Application
  • 6.3.1 North America Biosimilar of Remicade Market Size by Application (2016-2021)
  • 6.3.2 North America Biosimilar of Remicade Market Size by Application (2022-2027)
  • 6.3.3 North America Biosimilar of Remicade Market Size by Application (2016-2027)
• 6.4 North America Biosimilar of Remicade Market Size by Country
  • 6.4.1 North America Biosimilar of Remicade Market Size by Country (2016-2021)
  • 6.4.2 North America Biosimilar of Remicade Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Biosimilar of Remicade Market Size (2016-2027)
• 7.2 Europe Biosimilar of Remicade Market Size by Type
  • 7.2.1 Europe Biosimilar of Remicade Market Size by Type (2016-2021)
  • 7.2.2 Europe Biosimilar of Remicade Market Size by Type (2022-2027)
  • 7.2.3 Europe Biosimilar of Remicade Market Size by Type (2016-2027)
• 7.3 Europe Biosimilar of Remicade Market Size by Application
  • 7.3.1 Europe Biosimilar of Remicade Market Size by Application (2016-2021)
  • 7.3.2 Europe Biosimilar of Remicade Market Size by Application (2022-2027)
  • 7.3.3 Europe Biosimilar of Remicade Market Size by Application (2016-2027)
• 7.4 Europe Biosimilar of Remicade Market Size by Country
  • 7.4.1 Europe Biosimilar of Remicade Market Size by Country (2016-2021)
  • 7.4.2 Europe Biosimilar of Remicade Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Biosimilar of Remicade Market Size (2016-2027)
• 8.2 Asia-Pacific Biosimilar of Remicade Market Size by Type
  • 8.2.1 Asia-Pacific Biosimilar of Remicade Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Biosimilar of Remicade Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Biosimilar of Remicade Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Biosimilar of Remicade Market Size by Application
  • 8.3.1 Asia-Pacific Biosimilar of Remicade Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Biosimilar of Remicade Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Biosimilar of Remicade Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Biosimilar of Remicade Market Size by Region
  • 8.4.1 Asia-Pacific Biosimilar of Remicade Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Biosimilar of Remicade Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Biosimilar of Remicade Market Size (2016-2027)
• 9.2 Latin America Biosimilar of Remicade Market Size by Type
  • 9.2.1 Latin America Biosimilar of Remicade Market Size by Type (2016-2021)
  • 9.2.2 Latin America Biosimilar of Remicade Market Size by Type (2022-2027)
  • 9.2.3 Latin America Biosimilar of Remicade Market Size by Type (2016-2027)
• 9.3 Latin America Biosimilar of Remicade Market Size by Application
  • 9.3.1 Latin America Biosimilar of Remicade Market Size by Application (2016-2021)
  • 9.3.2 Latin America Biosimilar of Remicade Market Size by Application (2022-2027)
  • 9.3.3 Latin America Biosimilar of Remicade Market Size by Application (2016-2027)
• 9.4 Latin America Biosimilar of Remicade Market Size by Country
  • 9.4.1 Latin America Biosimilar of Remicade Market Size by Country (2016-2021)
  • 9.4.2 Latin America Biosimilar of Remicade Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Biosimilar of Remicade Market Size (2016-2027)
• 10.2 Middle East & Africa Biosimilar of Remicade Market Size by Type
  • 10.2.1 Middle East & Africa Biosimilar of Remicade Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Biosimilar of Remicade Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Biosimilar of Remicade Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Biosimilar of Remicade Market Size by Application
  • 10.3.1 Middle East & Africa Biosimilar of Remicade Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Biosimilar of Remicade Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Biosimilar of Remicade Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Biosimilar of Remicade Market Size by Country
  • 10.4.1 Middle East & Africa Biosimilar of Remicade Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Biosimilar of Remicade Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Synthon Pharmaceuticals
  • 11.1.1 Synthon Pharmaceuticals Company Details
  • 11.1.2 Synthon Pharmaceuticals Business Overview
  • 11.1.3 Synthon Pharmaceuticals Biosimilar of Remicade Introduction
  • 11.1.4 Synthon Pharmaceuticals Revenue in Biosimilar of Remicade Business (2016-2021)
  • 11.1.5 Synthon Pharmaceuticals Recent Development
• 11.2 LG Life Sciences
  • 11.2.1 LG Life Sciences Company Details
  • 11.2.2 LG Life Sciences Business Overview
  • 11.2.3 LG Life Sciences Biosimilar of Remicade Introduction
  • 11.2.4 LG Life Sciences Revenue in Biosimilar of Remicade Business (2016-2021)
  • 11.2.5 LG Life Sciences Recent Development
• 11.3 Novartis (Sandoz)
  • 11.3.1 Novartis (Sandoz) Company Details
  • 11.3.2 Novartis (Sandoz) Business Overview
  • 11.3.3 Novartis (Sandoz) Biosimilar of Remicade Introduction
  • 11.3.4 Novartis (Sandoz) Revenue in Biosimilar of Remicade Business (2016-2021)
  • 11.3.5 Novartis (Sandoz) Recent Development
• 11.4 Celltrion
  • 11.4.1 Celltrion Company Details
  • 11.4.2 Celltrion Business Overview
  • 11.4.3 Celltrion Biosimilar of Remicade Introduction
  • 11.4.4 Celltrion Revenue in Biosimilar of Remicade Business (2016-2021)
  • 11.4.5 Celltrion Recent Development
• 11.5 Biocon
  • 11.5.1 Biocon Company Details
  • 11.5.2 Biocon Business Overview
  • 11.5.3 Biocon Biosimilar of Remicade Introduction
  • 11.5.4 Biocon Revenue in Biosimilar of Remicade Business (2016-2021)
  • 11.5.5 Biocon Recent Development
• 11.6 Hospira
  • 11.6.1 Hospira Company Details
  • 11.6.2 Hospira Business Overview
  • 11.6.3 Hospira Biosimilar of Remicade Introduction
  • 11.6.4 Hospira Revenue in Biosimilar of Remicade Business (2016-2021)
  • 11.6.5 Hospira Recent Development
• 11.7 Merck Serono (Merck Group)
  • 11.7.1 Merck Serono (Merck Group) Company Details
  • 11.7.2 Merck Serono (Merck Group) Business Overview
  • 11.7.3 Merck Serono (Merck Group) Biosimilar of Remicade Introduction
  • 11.7.4 Merck Serono (Merck Group) Revenue in Biosimilar of Remicade Business (2016-2021)
  • 11.7.5 Merck Serono (Merck Group) Recent Development
• 11.8 Biogen idec Inc.
  • 11.8.1 Biogen idec Inc. Company Details
  • 11.8.2 Biogen idec Inc. Business Overview
  • 11.8.3 Biogen idec Inc. Biosimilar of Remicade Introduction
  • 11.8.4 Biogen idec Inc. Revenue in Biosimilar of Remicade Business (2016-2021)
  • 11.8.5 Biogen idec Inc. Recent Development
• 11.9 Genentech (Roche Group)
  • 11.9.1 Genentech (Roche Group) Company Details
  • 11.9.2 Genentech (Roche Group) Business Overview
  • 11.9.3 Genentech (Roche Group) Biosimilar of Remicade Introduction
  • 11.9.4 Genentech (Roche Group) Revenue in Biosimilar of Remicade Business (2016-2021)
  • 11.9.5 Genentech (Roche Group) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer